| 000 | 01817 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513135729.0 | ||
| 264 | 0 | _c19980423 | |
| 008 | 199804s 0 0 ger d | ||
| 022 | _a0044-3220 | ||
| 024 | 7 |
_a10.1055/s-2008-1039743 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGanzer, D | |
| 245 | 0 | 0 |
_a[Prevention of thromboembolism as a cause of thromboembolic complications. A study of the incidence of heparin-induced thrombocytopenia type II]. _h[electronic resource] |
| 260 |
_bZeitschrift fur Orthopadie und ihre Grenzgebiete _c |
||
| 300 |
_a543-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeparin _xadministration & dosage |
| 650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _xadministration & dosage |
| 650 | 0 | 4 | _aHip Prosthesis |
| 650 | 0 | 4 |
_aHirudins _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aKnee Prosthesis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOrthopedics |
| 650 | 0 | 4 |
_aPlatelet Activation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Count _xdrug effects |
| 650 | 0 | 4 |
_aPostoperative Complications _xblood |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aThrombocytopenia _xblood |
| 650 | 0 | 4 |
_aThromboembolism _xblood |
| 650 | 0 | 4 |
_aThrombophlebitis _xblood |
| 700 | 1 | _aGutezeit, A | |
| 700 | 1 | _aMayer, G | |
| 700 | 1 | _aGreinacher, A | |
| 700 | 1 | _aEichler, P | |
| 773 | 0 |
_tZeitschrift fur Orthopadie und ihre Grenzgebiete _gvol. 135 _gno. 6 _gp. 543-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-2008-1039743 _zAvailable from publisher's website |
| 999 |
_c9467597 _d9467597 |
||